Hannah J Jones

Dr. Hannah J Jones

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CSClaudia L Satizabal
Claudia L Satizabal
HAHieab H H Adams
Hieab H H Adams
DHDerrek P Hibar
Derrek P Hibar
CWCharles C White
Charles C White
MKMaria J Knol
Maria J Knol
MIM Arfan Ikram
M Arfan Ikram

1 March 2016 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
HJHannah J Jones
Hannah J Jones
ESEvangelia Stergiakouli
Evangelia Stergiakouli
KTKatherine E. Tansey
Katherine E. Tansey
LHLeon Hubbard
Leon Hubbard
JHJon Heron
Jon Heron
SZStanley Zammit
Stanley Zammit
Schizophrenia has a heritability of approximately 80%, and genome-wide association studies (GWASs) indicate that multiple independent loci contribute to its etiology.1 The importance of studying the phenotypic manifestations of increased genetic liability for schizophrenia has been long recognized and originally involved small samples of individuals at high risk as indexed by having a family history.2 Genetic advances now provide the opportunity to extend the power and generalizability of high-risk studies into the general population by examining individuals according to genetic risk. Although individual loci have small effects on risk, multiple-loci approaches show that, cumulatively, alleles on current GWAS platforms explain one-half to one-third of the genetic risk for schizophrenia.3,4 Information from even moderately associated alleles can be collapsed into a single polygenic risk score (PRS) that can be used to explore shared genetic effects with other disorders and to examine how genetic risk is manifest early during development.5

1 December 2021 in The Lancet Psychiatry
Verified
Journal Article
Closed access
HJHannah J Jones
Hannah J Jones
MBMaria Carolina Borges
Maria Carolina Borges
RCRebecca Carnegie
Rebecca Carnegie
DMDavid Mongan
David Mongan
PRPeter J Rogers
Peter J Rogers
SZStanley Zammit
Stanley Zammit

4 June 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
RWRobyn E. Wootton
Robyn E. Wootton
HJHannah J Jones
Hannah J Jones
HSHannah M. Sallis
Hannah M. Sallis
The successful prevention of mental illness relies upon the identification of causal, modifiable risk factors. However, observational evidence exploring such risk factors often produces contradictory results and randomised control trials are often expensive, time-consuming or unethical to conduct. Mendelian randomisation (MR) is a complementary approach that uses naturally occurring genetic variation to identify possible causal effects between a risk factor and an outcome in a time-efficient and low-cost manner. MR utilises genetic variants as instrumental variables for the risk factor of interest. MR studies are becoming more frequent in the field of psychiatry, warranting a reflection upon both the possibilities and the pitfalls. In this Perspective, we consider several limitations of the MR method that are of particular relevance to psychiatry. We also present new MR methods that have exciting applications to questions of mental illness. While we believe that MR can make an important contribution to the field of psychiatry, we also wish to emphasise the importance of clear causal questions, thorough sensitivity analyses, and triangulation with other forms of evidence.

8 August 2018 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
HJHannah J Jones
Hannah J Jones
JHJon Heron
Jon Heron
Gemma HammertonGemma Hammerton
Gemma Hammerton
JSJan Stochl
Jan Stochl
PJPeter Martin Jones
Peter Martin Jones
SZStanley Zammit
Stanley Zammit
Whilst associations between polygenic risk scores (PRSs) for schizophrenia and various phenotypic outcomes have been reported, an understanding of developmental pathways can only be gained by modelling comorbidity across psychopathology. We examine how genetic risk for schizophrenia relates to adolescent psychosis-related and internalizing psychopathology using a latent modelling approach, and compare this to genetic risk for other psychiatric disorders, to gain a more comprehensive understanding of the developmental pathways at this age. PRSs for schizophrenia, major depressive disorder, neuroticism and bipolar disorder were generated for individuals in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort. Multivariate linear regression was used to examine the relationships of these PRSs with psychopathology factors modelled within (i) a correlated factors structure and (ii) a bifactor structure. The schizophrenia PRS was associated with an increase in factors describing psychotic experiences, negative dimension, depression and anxiety, but, when modelling a general psychopathology factor based on these measures, specific effects above this persisted only for the negative dimension. Similar factor relationships were observed for the neuroticism PRS, with a (weak) specific effect only for anxiety once modelling general psychopathology. Psychopathology during adolescence can be described by a general psychopathology construct that captures common variance as well as by specific constructs capturing remaining non-shared variance. Schizophrenia risk genetic variants identified through genome-wide association studies mainly index negative rather than positive symptom psychopathology during adolescence. This has potentially important implications both for research and risk prediction in high-risk samples.

1 March 2018 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
HJHannah J Jones
Hannah J Jones
SGSuzanne H. Gage
Suzanne H. Gage
JHJon Heron
Jon Heron
MHMatthew Hickman
Matthew Hickman
GLGlyn Lewis
Glyn Lewis
SZStanley Zammit
Stanley Zammit
Cannabis and tobacco are frequently used together, identifying their individual associations on mental health is difficult but important, as this can advance understanding of causal mechanisms and help target preventive interventions.